we prospectively evaluated the incidence of thrombocytopenia in 43 patients receiving intravenous continuous infusions of either bovine lung heparin , manufactured by a new process , or a standard porcine intestinal mucosa heparin for a minimum of five days in a double-blind , randomized fashion .
C0040034
thrombocytopenia
C0019134
heparin